Measurement of chemotherapy-induced alopecia - time to change

Support Care Cancer. 2015 May;23(5):1197-9. Epub 2015 Feb 10.
Type:
Commentary
PMID:
25663579
DOI:
10.1007/s00520-015-2647-3
Authors:

C J G van den Hurk1, J Winstanley, A Young, F Boyle

Author Affiliations:

1Research Department, Comprehensive Cancer Centre South, PO Box 231, 5600 AE Eindhoven, The Netherlands.

Abstract
Purpose

Data on chemotherapy-induced alopecia (CIA) as a side effect of cancer treatment are scarce. CIA is given minimal attention in clinical trials and in the literature. However, when asking the patients with cancer for their opinion, CIA appears to have a major impact, particularly on body image and quality of life. Currently, there is no commonly used measure to evaluate CIA; It is time to improve the management and measurement of CIA.

Related Papers: